Related Experiment Videos
DNA vaccination and the immune responsiveness of neonates
1Department of Exploratory Biological Research, Alliance Pharmaceutical Corp., San Diego, CA 92121, USA. axb@allp.com
Insights
Neonatal DNA vaccination typically induces immunity, not tolerance, challenging the notion of immature immune responses. Maternal antibodies may only partially inhibit this process, offering insights into vaccine mechanisms.
Area of Science:
- Immunology
- Vaccinology
- Neonatal Development
Background:
- Neonates exhibit suboptimal responses to conventional vaccines and infections, often attributed to immune system immaturity.
- Emerging evidence suggests that neonatal antigen exposure can induce protective immunity under specific circumstances.
Purpose of the Study:
- To investigate the immune response to DNA vaccines in neonates.
- To explore the mechanisms underlying neonatal responsiveness to DNA vaccination.
- To understand the role of maternal antibodies in neonatal DNA vaccination.
Main Methods:
- Administration of DNA vaccines to neonatal models.
- Assessment of immune responses, including protective immunity and tolerance induction.
- Evaluation of the impact of maternal antibodies on vaccine efficacy.
Main Results:
- Neonatal DNA vaccination predominantly leads to immunity rather than tolerance.
- Maternal antibodies may have a limited inhibitory effect, primarily on humoral immunity, due to the DNA vaccine vector's nature.
Conclusions:
- Neonatal immune system can mount effective responses to DNA vaccines.
- DNA vaccination represents a promising strategy for neonatal immunization.
- Further research is needed to fully elucidate the mechanisms of neonatal immune responses to DNA vaccines.
Abstract:
Neonates often respond poorly to conventional vaccines or microbial infections. Immaturity of the immune system has been considered to play a role in this regard. However, accumulating evidence shows that in certain conditions, neonatal inoculation of antigens leads to protective immunity. In the particular case of DNA vaccines administered to neonates, the rule is immunity rather than tolerance. Exceptions to the rule give opportunities to further understand the neonatal responsiveness and the mechanism of DNA vaccination. Due to the very nature of the vaccine vector, inhibition of neonatal DNA vaccination by maternal antibodies may be limited to the humoral immunity.